Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorEscola Verge, Laura
dc.contributor.authorCorona Pérez-Cardona, Pablo Salvador
dc.contributor.authorPigrau Serrallach, Carles
dc.contributor.authorRodríguez Pardo, Ma Dolores
dc.date.accessioned2021-12-07T13:31:46Z
dc.date.available2021-12-07T13:31:46Z
dc.date.issued2021-04
dc.identifier.citationEscolà-Vergé L, Rodríguez-Pardo D, Corona PS, Pigrau C. Candida Periprosthetic Joint Infection: Is It Curable? Antibiotics. 2021 Apr;10:458.
dc.identifier.issn2079-6382
dc.identifier.urihttps://hdl.handle.net/11351/6663
dc.descriptionFungus; Periprosthetic joint infection; Two-stage exchange surgery
dc.description.abstractCandida periprosthetic joint infection (CPJI) is a rare and very difficult to treat infection, and high-quality evidence regarding the best management is scarce. Candida spp. adhere to medical devices and grow forming biofilms, which contribute to the persistence and relapse of this infection. Typically, CPJI presents as a chronic infection in a patient with multiple previous surgeries and long courses of antibiotic therapy. In a retrospective series of cases, the surgical approach with higher rates of success consists of a two-stage exchange surgery, but the best antifungal treatment and duration of antifungal treatment are still unclear, and the efficacy of using an antifungal agent-loaded cement spacer is still controversial. Until more evidence is available, focusing on prevention and identifying patients at risk of CPJI seems more than reasonable.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesAntibiotics;10
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCandidiasi - Tractament
dc.subjectPròtesis - Complicacions
dc.subject.meshCandidiasis
dc.subject.mesh/therapy
dc.subject.meshProsthesis-Related Infections
dc.titleCandida Periprosthetic Joint Infection: Is It Curable?
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/antibiotics10040458
dc.subject.decscandidiasis
dc.subject.decs/terapia
dc.subject.decsinfecciones relacionadas con prótesis
dc.relation.publishversionhttps://doi.org/10.3390/antibiotics10040458
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Escolà-Vergé L, Rodríguez-Pardo D, Pigrau C] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, 28029 Madrid, Spain. Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC), 28003 Madrid, Spain. [Corona PS] Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, 28029 Madrid, Spain. Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC), 28003 Madrid, Spain. Unitat de Cirurgia Sèptica i Reconstructiva, Servei de Cirurgia Ortopèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid33920619
dc.identifier.wos000642704600001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record